Haemonetics Corporation (HAE) vs LivaNova PLC (LIVN)
Haemonetics Corporation and LivaNova PLC are both Medical Devices companies. Haemonetics Corporation is the larger, with a market value of $4.8B against $4.2B — 1.2× the size. LivaNova PLC trades at the lower P/E: 22.2× against 51.4×. LivaNova PLC grew revenue faster over the last twelve months: 12.4% against 0.44%. LivaNova PLC has the higher net margin (12.8% vs 7.12%) and the higher return on invested capital (10.6% vs 5.62%). Across the 22 metrics below, LivaNova PLC leads on 15 and Haemonetics Corporation on 7.
Valuation
Profitability
| Metric | HAE | LIVN | Medical Devices median |
|---|---|---|---|
| Gross margin | 59.03% | 68.10% | 56.01% |
| Operating margin | 11.86% | 12.74% | (15.03%) |
| Net margin | 7.12% | 12.81% | (20.40%) |
| Free cash flow margin | 21.64% | 10.57% | (7.24%) |
| Return on equity | 11.20% | 15.40% | (15.32%) |
| Return on assets | 3.99% | 7.33% | (19.72%) |
| Return on invested capital | 5.62% | 10.63% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack